Actimmune (Interferon Gamma-1b) Gains Expanded Approval For Severe Osteopetrosis In Pediatric Patients
March 29, 2025 – Horizon Therapeutics, the manufacturer of Actimmune® (interferon gamma-1b), has announced that the U.S.…
News
Augtyro (Repotrectinib) Capsules: What Patients Really Want to Know
If you or a loved one has been prescribed Augtyro Repotrectinib for non-small cell lung…
Lorviqua (Lorlatinib) Approved In EU For First-Line Treatment Of ALK-Positive Non-Small Cell Lung Cancer
Pfizer Inc. recently announced that its third-generation anaplastic lymphoma kinase (ALK) inhibitor Lorviqua (generic name:…
BETAGRIN Announces Revolutionary New Energy Solution To Lead The Future Of Green Technology
[Global, October 15, 2023] – Today, BETAGRIN, a leading global green technology company, officially announced…
Golidocitinib Capsules: A breakthrough In A New Generation Of JAK1 Inhibitors
Among the latest advances in the pharmaceutical field, Golidocitinib Capsules, a new generation of JAK1…
FDA Accelerates Approval Of TALVEY™ (Talquetamab-tgvs) For The Treatment Of Multiple Myeloma
On 9 August 2023, the US Food and Drug Administration (FDA) announced the accelerated approval…
Astellas Pharmaceuticals Group: Driven By Innovation
March 19, 2025 – Astellas Pharma Group (TSE: 4503) continues to demonstrate its innovative strength…
Aclidinium Bromide Drug: A Promising For COPD Treatment
In recent years, the pharmaceutical industry has witnessed significant advancements in the treatment of chronic…
Fulzerasib Tablets: A New Era In Targeted Cancer Therapy
In a major breakthrough for precision oncology, Fulzerasib tablets have emerged as a promising treatment…
Iclusig: A Breakthrough In The Treatment Of Drug-Resistant Leukemia
In a significant advancement in the fight against leukemia, Iclusig (ponatinib) continues to demonstrate its…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights